Amanote Research
Register
Sign In
618. Adjunctive Γ2-Agonist Therapy Enhances Trafficking of Acid Α-Glucosidase to Lysosomes in the Skeletal Muscle of Mice With Pompe Disease
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)34953-x
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2013
Authors
Unknown
Publisher
Elsevier BV
Related search
Glycosylation-Independent Lysosomal Targeting of Acid Α-Glucosidase Enhances Muscle Glycogen Clearance in Pompe Mice
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Structure of Human Lysosomal Acid Α-Glucosidase–A Guide for the Treatment of Pompe Disease
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Cardiac Remodeling and Contractile Function in Acid Α-Glucosidase Knockout Mice
Physiological Genomics
Genetics
Physiology
Assessment of Adeno-Associated Virus Gene Therapies Efficacy on Acid Alpha-Glucosidase Restoration and Glycogen Storage Correction in Cardiac Muscle of Pompe Disease Mice Using Synchrotron Infrared and Ultraviolet Microspectroscopies
Journal of Spectral Imaging
Analytical Chemistry
Spectroscopy
Correcting Neuromuscular Deficits With Gene Therapy in Pompe Disease
Annals of Neurology
Neurology
Co-Existing Proteins Interfere With the Action of Nordihydroguaiaretic Acid on Retrograde Golgi-To-Er Protein Trafficking in NRK Cells and Α-Glucosidase Reaction in Vitro
Bioscience, Biotechnology and Biochemistry
Organic Chemistry
Applied Microbiology
Molecular Biology
Biochemistry
Analytical Chemistry
Medicine
Biotechnology
Assessment of Toxicity and Biodistribution of Recombinant AAV8 Vector–mediated Immunomodulatory Gene Therapy in Mice With Pompe Disease
Molecular Therapy - Methods and Clinical Development
Molecular Medicine
Genetics
Molecular Biology
PHP7 Recent Developments in Pompe Disease Therapy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
472. Evaluation of Re-Administration of a Recombinant Adeno-Associated Vector Expressing Acid-Alpha-Glucosidase (rAAV9-DES-hGAA) in Pompe Disease: Preclinical to Clinical Planning
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery